To address the evolving treatment needs of people living with HIV/AIDS in the poorest and most vulnerable countries, ViiV Healthcare has announced a new series of initiatives, including:
Improving access to medicines by granting generic manufacturers royalty free licenses to the whole portfolio of ViiV Healthcare antiretroviral medicinesExpanding the number of countries that can benefit from this arrangement to include all least developed countries, all low income countries and all of sub-Saharan Africa – that is 80% of all people currently living with HIV